Article

A community-based collaboration to build prediction models for short-term discontinuation of docetaxel in metastatic castration-resistant prostate cancer

2016-11-15

Abstract excerpt

<h4>Background</h4> Docetaxel has a demonstrated survival benefit for metastatic castration-resistant prostate cancer (mCRPC). However, 10-20% of patients discontinue docetaxel prematurely because of toxicity-induced adverse events, and managing risk factors for toxicity remains an ongoing challenge for health care providers and patients. Prospective identification of high-risk patients for early discontinuation...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b59a1255-02a5-5056-8c73-d074e38054d0
DOI: 10.1101/087809

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A community-based collaboration to build prediction models for short-term discontinuation of docetaxel in metastatic castration-resistant prostate cancerDOI 10.1101/087809Read

A predictive model of overall survival in patients with metastatic castration-resistant prostate cancerSemantic proximity Read

Three general concepts to improve risk prediction: good data, wisdom of the crowd, recalibrationSemantic proximity Read

A Community Challenge to Predict Clinical Outcomes After Immune Checkpoint Blockade in Non-Small Cell Lung CancerSemantic proximity Read

Predicting survival time for metastatic castration resistant prostate cancer: An iterative imputation approachSemantic proximity Read

Protocol Complexity and Trial Failure: Predictive Modeling for Early Feasibility Assessment in Drug and Device DevelopmentSemantic proximity Read

Survival prognosis and variable selection: A case study for metastatic castrate resistant prostate cancer patientsSemantic proximity Read

Exploring scalable assessment methods for terminated trials in ClinicalTrials.gov: A cohort analysis of German and Californian trialsSemantic proximity Read

Early treatment outcome prediction in metastatic castration-resistant prostate cancer utilizing 3-month tumor growth rate ( <i>g</i> -rate) based machine learning modelSemantic proximity Read

Appropriateness of Prostate Cancer Prevention and Screening Recommendations Obtained From ChatGPT-4Semantic proximity Read

A Python-Based Interactive Web Tool for Dual-Task Prediction of Treatment Response and Adverse Events in MINIC3 Immunotherapy: A Proof-of-Concept StudySemantic proximity Read

Evaluation of imputation strategies for multi-centre studies: Application to a large clinical pathology datasetSemantic proximity Read

Calendar Period Estimation of Probabilities of Transition in Drug DevelopmentSemantic proximity Read